Aligos Therapeutics Insider Trades

ALGS

Track insider trading activity from Aligos Therapeutics executives and directors. See which insiders are buying and selling ALGS stock.

Trades Last 12 Months

ALGS Price

All Insider Trades for Aligos Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Calhoun Lesley Ann See Remarks
Holding Value $193k 37,485 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 37,485 shares
$7.03
$5.14
Aneja Nikhil Principal Accounting Officer
Holding Value $48.6k 9,450 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66.4k 9,450 shares
$7.03
$5.14
Blatt Lawrence President And CEO
Holding Value $544k 105,840 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 105,840 shares
$7.03
$5.14
Symons Julian A. See Remarks
Holding Value $82.2k 16,000 shares
Last Trade
Jul 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 16,000 shares
$8.68
$5.14
Scopa James Paul Director
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Chavez Margarita Director
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Hirth Peter Director
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Preston Heather Director
Holding Value $30.1k 5,860 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.7k 5,860 shares
$7.63
$5.14
Achneck Hardean Chief Medical Officer
Holding Value $386k 75,000 shares
Last Trade
Oct 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$549k 75,000 shares
$7.32
$5.14
Mcclure Matthew W. Chief Medical Officer
Holding Value $370k 72,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 72,000 shares
$28.25
$5.14
Nielsen Jack Director
Holding Value $22.7k 4,411 shares
Last Trade
Feb 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 4,411 shares
$24.00
$5.14
Roche Holding Ltd 10% owner
Holding Value $56.7M 11,025,941 shares
Last Trade
Oct 25, 2023 Sale
$61M 3,966,800 shares
$15.37
$5.14
Quan Lucinda Y. See Remarks
Holding Value $247k 48,000 shares
Last Trade
Sep 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 48,000 shares
$21.00
$5.14
Beigelman Leonid President
Holding Value $871k 169,500 shares
Last Trade
Mar 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.68M 169,500 shares
$33.50
$5.14
Woiwode Thomas Director
Holding Value $77.1k 15,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$503k 15,000 shares
$33.50
$5.14
Holding Value $4.43M 862,444 shares
Last Trade
Oct 20, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$66M 200,000 shares
$330.00
$5.14
Holding Value $16M 3,116,658 shares
Last Trade
Oct 20, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$182M 550,000 shares
$330.00
$5.14
Novo Holdings A/S 10% owner
Holding Value $12.4M 2,414,563 shares
Last Trade
Oct 20, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$797M 2,414,563 shares
$330.00
$5.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up